{"id": "R45069", "inputs": [{"text": "drug compounding is a process by which a pharmacist or physician combines , mixes , or alters various drug ingredients to create a drug to meet the unique needs of an individual patient .", "tokens": ["drug", "compounding", "is", "a", "process", "by", "which", "a", "pharmacist", "or", "physician", "combines", ",", "mixes", ",", "or", "alters", "various", "drug", "ingredients", "to", "create", "a", "drug", "to", "meet", "the", "unique", "needs", "of", "an", "individual", "patient", "."], "sentence_id": 1, "word_count": 34}, {"text": "compounded drugs include both nonsterile products ( e.g. , capsules and ointments ) and sterile products ( e.g. , injectable and ophthalmic products ) .", "tokens": ["compounded", "drugs", "include", "both", "nonsterile", "products", "(", "e.g", ".", ",", "capsules", "and", "ointments", ")", "and", "sterile", "products", "(", "e.g", ".", ",", "injectable", "and", "ophthalmic", "products", ")", "."], "sentence_id": 2, "word_count": 27}, {"text": "in situations where a product approved by the food and drug administration ( fda ) would not be medically appropriate to treat a patient , a pharmacist or physician may formulate and dispense or administer a compounded drug product .", "tokens": ["in", "situations", "where", "a", "product", "approved", "by", "the", "food", "and", "drug", "administration", "(", "fda", ")", "would", "not", "be", "medically", "appropriate", "to", "treat", "a", "patient", ",", "a", "pharmacist", "or", "physician", "may", "formulate", "and", "dispense", "or", "administer", "a", "compounded", "drug", "product", "."], "sentence_id": 3, "word_count": 40}, {"text": "for example , a patient with an allergy may need a medication without a certain dye , or an elderly person with a limited ability to swallow may need a medication in liquid form that is not commercially available .", "tokens": ["for", "example", ",", "a", "patient", "with", "an", "allergy", "may", "need", "a", "medication", "without", "a", "certain", "dye", ",", "or", "an", "elderly", "person", "with", "a", "limited", "ability", "to", "swallow", "may", "need", "a", "medication", "in", "liquid", "form", "that", "is", "not", "commercially", "available", "."], "sentence_id": 4, "word_count": 40}, {"text": "the federal food , drug , and cosmetic act ( ffdca ) authorizes fda to regulate the manufacturing and sale of drugs in the united states , including compounded drugs .", "tokens": ["the", "federal", "food", ",", "drug", ",", "and", "cosmetic", "act", "(", "ffdca", ")", "authorizes", "fda", "to", "regulate", "the", "manufacturing", "and", "sale", "of", "drugs", "in", "the", "united", "states", ",", "including", "compounded", "drugs", "."], "sentence_id": 5, "word_count": 31}, {"text": "generally , a new drug may not be sold unless the fda , through its drug approval process , has determined that the drug is safe and effective for its intended use .", "tokens": ["generally", ",", "a", "new", "drug", "may", "not", "be", "sold", "unless", "the", "fda", ",", "through", "its", "drug", "approval", "process", ",", "has", "determined", "that", "the", "drug", "is", "safe", "and", "effective", "for", "its", "intended", "use", "."], "sentence_id": 6, "word_count": 33}, {"text": "the ffdca defines a new drug to be a drug \"the composition of which is such that such drug is not generally recognized ... as safe and effective for use under the conditions prescribed , recommended , or suggested in the labeling thereof. .", "tokens": ["the", "ffdca", "defines", "a", "new", "drug", "to", "be", "a", "drug", "``", "the", "composition", "of", "which", "is", "such", "that", "such", "drug", "is", "not", "generally", "recognized", "...", "as", "safe", "and", "effective", "for", "use", "under", "the", "conditions", "prescribed", ",", "recommended", ",", "or", "suggested", "in", "the", "labeling", "thereof", ".", "."], "sentence_id": 7, "word_count": 46}, {"text": "although compounded drugs are considered new drugs , it would not be practicable for pharmacies to obtain approval for each drug compounded for an individual patient .", "tokens": ["although", "compounded", "drugs", "are", "considered", "new", "drugs", ",", "it", "would", "not", "be", "practicable", "for", "pharmacies", "to", "obtain", "approval", "for", "each", "drug", "compounded", "for", "an", "individual", "patient", "."], "sentence_id": 8, "word_count": 27}, {"text": "thus , compounded drugs are not evaluated by fda prior to marketing for safety or effectiveness and until the 1990s , responsibility for overseeing and regulating drug compounding has generally been left to the states .", "tokens": ["thus", ",", "compounded", "drugs", "are", "not", "evaluated", "by", "fda", "prior", "to", "marketing", "for", "safety", "or", "effectiveness", "and", "until", "the", "1990s", ",", "responsibility", "for", "overseeing", "and", "regulating", "drug", "compounding", "has", "generally", "been", "left", "to", "the", "states", "."], "sentence_id": 9, "word_count": 36}, {"text": "historically , pharmacy compounding has been regulated by state entities ( e.g. , state boards of pharmacy ) , and the frequency of inspections and level of oversight by state regulators has varied .", "tokens": ["historically", ",", "pharmacy", "compounding", "has", "been", "regulated", "by", "state", "entities", "(", "e.g", ".", ",", "state", "boards", "of", "pharmacy", ")", ",", "and", "the", "frequency", "of", "inspections", "and", "level", "of", "oversight", "by", "state", "regulators", "has", "varied", "."], "sentence_id": 10, "word_count": 35}, {"text": "in response to concerns surrounding the practice of large - scale compounding that resembled drug manufacturing , in 1992 , fda issued guidance explaining the types of compounding that may be subject to enforcement action by the agency .", "tokens": ["in", "response", "to", "concerns", "surrounding", "the", "practice", "of", "large", "-", "scale", "compounding", "that", "resembled", "drug", "manufacturing", ",", "in", "1992", ",", "fda", "issued", "guidance", "explaining", "the", "types", "of", "compounding", "that", "may", "be", "subject", "to", "enforcement", "action", "by", "the", "agency", "."], "sentence_id": 11, "word_count": 39}, {"text": "congress provided statutory authority for portions of the guidance in ffdca section 503a .", "tokens": ["congress", "provided", "statutory", "authority", "for", "portions", "of", "the", "guidance", "in", "ffdca", "section", "503a", "."], "sentence_id": 12, "word_count": 14}, {"text": "in response to the 2012 fungal meningitis outbreak and a series of adverse event reports and quality problems linked to compounding facilities , congress held a series of hearings , which led to the enactment of the cqa in november 2013 .", "tokens": ["in", "response", "to", "the", "2012", "fungal", "meningitis", "outbreak", "and", "a", "series", "of", "adverse", "event", "reports", "and", "quality", "problems", "linked", "to", "compounding", "facilities", ",", "congress", "held", "a", "series", "of", "hearings", ",", "which", "led", "to", "the", "enactment", "of", "the", "cqa", "in", "november", "2013", "."], "sentence_id": 13, "word_count": 42}, {"text": "the law established ffdca section 503b and created a new category of drug compounders called outsourcing facilities .", "tokens": ["the", "law", "established", "ffdca", "section", "503b", "and", "created", "a", "new", "category", "of", "drug", "compounders", "called", "outsourcing", "facilities", "."], "sentence_id": 14, "word_count": 18}, {"text": "entities that compound drugs in ways that exceed the circumstances described in section 503a ( i.e. , facilities that compound drugs in bulk for use in hospitals or other facilities ) may register with fda as such .", "tokens": ["entities", "that", "compound", "drugs", "in", "ways", "that", "exceed", "the", "circumstances", "described", "in", "section", "503a", "(", "i.e", ".", ",", "facilities", "that", "compound", "drugs", "in", "bulk", "for", "use", "in", "hospitals", "or", "other", "facilities", ")", "may", "register", "with", "fda", "as", "such", "."], "sentence_id": 15, "word_count": 39}, {"text": "an outsourcing facility is defined as a facility at one geographic location or address that is engaged in the compounding of sterile drugs , has elected to register as an outsourcing facility , and complies with all the requirements of section 503b .", "tokens": ["an", "outsourcing", "facility", "is", "defined", "as", "a", "facility", "at", "one", "geographic", "location", "or", "address", "that", "is", "engaged", "in", "the", "compounding", "of", "sterile", "drugs", ",", "has", "elected", "to", "register", "as", "an", "outsourcing", "facility", ",", "and", "complies", "with", "all", "the", "requirements", "of", "section", "503b", "."], "sentence_id": 16, "word_count": 43}, {"text": "since the enactment of the cqa , fda has issued numerous draft and final guidance documents to explain its policy on certain requirements and facilitate implementation of the compounding provisions under ffdca sections 503a and 503b .", "tokens": ["since", "the", "enactment", "of", "the", "cqa", ",", "fda", "has", "issued", "numerous", "draft", "and", "final", "guidance", "documents", "to", "explain", "its", "policy", "on", "certain", "requirements", "and", "facilitate", "implementation", "of", "the", "compounding", "provisions", "under", "ffdca", "sections", "503a", "and", "503b", "."], "sentence_id": 17, "word_count": 37}, {"text": "the agency also has issued a draft mou addressing the interstate distribution of certain compounded drug products .", "tokens": ["the", "agency", "also", "has", "issued", "a", "draft", "mou", "addressing", "the", "interstate", "distribution", "of", "certain", "compounded", "drug", "products", "."], "sentence_id": 18, "word_count": 18}, {"text": "additionally , since enactment of the cqa , fda has conducted over 400 inspections of drug compounders , issued more than 150 warning letters advising compounders of violations of federal law , and overseen more than 125 recall events .", "tokens": ["additionally", ",", "since", "enactment", "of", "the", "cqa", ",", "fda", "has", "conducted", "over", "400", "inspections", "of", "drug", "compounders", ",", "issued", "more", "than", "150", "warning", "letters", "advising", "compounders", "of", "violations", "of", "federal", "law", ",", "and", "overseen", "more", "than", "125", "recall", "events", "."], "sentence_id": 19, "word_count": 40}, {"text": "fda also has communicated with stakeholders and state regulators via annual listening sessions , a notice - and - comment guidance development process , intergovernmental meetings , and information posted to the fda website , among other things .", "tokens": ["fda", "also", "has", "communicated", "with", "stakeholders", "and", "state", "regulators", "via", "annual", "listening", "sessions", ",", "a", "notice", "-", "and", "-", "comment", "guidance", "development", "process", ",", "intergovernmental", "meetings", ",", "and", "information", "posted", "to", "the", "fda", "website", ",", "among", "other", "things", "."], "sentence_id": 20, "word_count": 39}, {"text": "as of december 2017 , fda's website lists 73 entities that have registered as outsourcing facilities .", "tokens": ["as", "of", "december", "2017", ",", "fda", "'s", "website", "lists", "73", "entities", "that", "have", "registered", "as", "outsourcing", "facilities", "."], "sentence_id": 21, "word_count": 18}, {"text": "because 503a compounding pharmacies are not required to register with fda and are generally overseen by state regulatory bodies , it is difficult to quantify the total number of these entities .", "tokens": ["because", "503a", "compounding", "pharmacies", "are", "not", "required", "to", "register", "with", "fda", "and", "are", "generally", "overseen", "by", "state", "regulatory", "bodies", ",", "it", "is", "difficult", "to", "quantify", "the", "total", "number", "of", "these", "entities", "."], "sentence_id": 22, "word_count": 32}, {"text": "in november 2016 , the government accountability office ( gao ) published a report on drug compounding that included results from a survey of state pharmacy regulatory bodies .", "tokens": ["in", "november", "2016", ",", "the", "government", "accountability", "office", "(", "gao", ")", "published", "a", "report", "on", "drug", "compounding", "that", "included", "results", "from", "a", "survey", "of", "state", "pharmacy", "regulatory", "bodies", "."], "sentence_id": 23, "word_count": 29}, {"text": "according to the report , most states that participated in the intergovernmental meetings found them to be helpful .", "tokens": ["according", "to", "the", "report", ",", "most", "states", "that", "participated", "in", "the", "intergovernmental", "meetings", "found", "them", "to", "be", "helpful", "."], "sentence_id": 24, "word_count": 19}, {"text": "of the 40 states that reported having had compounding - related communication with fda , 60% ( 24 states ) reported being very or somewhat satisfied with the communication , whereas 23% ( 9 states ) reported being very or somewhat dissatisfied .", "tokens": ["of", "the", "40", "states", "that", "reported", "having", "had", "compounding", "-", "related", "communication", "with", "fda", ",", "60", "%", "(", "24", "states", ")", "reported", "being", "very", "or", "somewhat", "satisfied", "with", "the", "communication", ",", "whereas", "23", "%", "(", "9", "states", ")", "reported", "being", "very", "or", "somewhat", "dissatisfied", "."], "sentence_id": 25, "word_count": 45}, {"text": "respondents in 15 states reported experiencing one or more communication challenges with fda , citing issues such as timeliness and difficulties getting the agency to respond to requests for information .", "tokens": ["respondents", "in", "15", "states", "reported", "experiencing", "one", "or", "more", "communication", "challenges", "with", "fda", ",", "citing", "issues", "such", "as", "timeliness", "and", "difficulties", "getting", "the", "agency", "to", "respond", "to", "requests", "for", "information", "."], "sentence_id": 26, "word_count": 31}, {"text": "other stakeholders , including certain compounding pharmacist and physician groups , have voiced concern regarding fda's interpretation and implementation of certain statutory provisions ( e.g. , the prescription requirement and draft mou ) .", "tokens": ["other", "stakeholders", ",", "including", "certain", "compounding", "pharmacist", "and", "physician", "groups", ",", "have", "voiced", "concern", "regarding", "fda", "'s", "interpretation", "and", "implementation", "of", "certain", "statutory", "provisions", "(", "e.g", ".", ",", "the", "prescription", "requirement", "and", "draft", "mou", ")", "."], "sentence_id": 27, "word_count": 36}, {"text": "stakeholders in this space include state regulators , pharmacists and physicians who compound drugs , outsourcing facilities , and the groups that represent these entities .", "tokens": ["stakeholders", "in", "this", "space", "include", "state", "regulators", ",", "pharmacists", "and", "physicians", "who", "compound", "drugs", ",", "outsourcing", "facilities", ",", "and", "the", "groups", "that", "represent", "these", "entities", "."], "sentence_id": 28, "word_count": 26}, {"text": "in response to the issues flagged by stakeholders , congress has responded by sending letters to fda , issuing directives in report language , and introducing legislation to amend the statutory provisions concerning compounding .", "tokens": ["in", "response", "to", "the", "issues", "flagged", "by", "stakeholders", ",", "congress", "has", "responded", "by", "sending", "letters", "to", "fda", ",", "issuing", "directives", "in", "report", "language", ",", "and", "introducing", "legislation", "to", "amend", "the", "statutory", "provisions", "concerning", "compounding", "."], "sentence_id": 29, "word_count": 35}, {"text": "the following sections discuss some of the issues that have been raised in response to fda's implementation of the compounding provisions , as well as the actions taken by congress .", "tokens": ["the", "following", "sections", "discuss", "some", "of", "the", "issues", "that", "have", "been", "raised", "in", "response", "to", "fda", "'s", "implementation", "of", "the", "compounding", "provisions", ",", "as", "well", "as", "the", "actions", "taken", "by", "congress", "."], "sentence_id": 30, "word_count": 32}, {"text": "this is not a comprehensive list of all of the issues flagged by interested parties , but rather a summary of selected issues that have been the subject of congressional letters to the agency , report directives , and legislation .", "tokens": ["this", "is", "not", "a", "comprehensive", "list", "of", "all", "of", "the", "issues", "flagged", "by", "interested", "parties", ",", "but", "rather", "a", "summary", "of", "selected", "issues", "that", "have", "been", "the", "subject", "of", "congressional", "letters", "to", "the", "agency", ",", "report", "directives", ",", "and", "legislation", "."], "sentence_id": 31, "word_count": 41}, {"text": "the three issues discussed are: ( 1 ) the prescription requirement and compounding for office - use , ( 2 ) the draft mou addressing interstate distribution of compounded drugs , and ( 3 ) inspections under cgmp requirements .", "tokens": ["the", "three", "issues", "discussed", "are", ":", "(", "1", ")", "the", "prescription", "requirement", "and", "compounding", "for", "office", "-", "use", ",", "(", "2", ")", "the", "draft", "mou", "addressing", "interstate", "distribution", "of", "compounded", "drugs", ",", "and", "(", "3", ")", "inspections", "under", "cgmp", "requirements", "."], "sentence_id": 32, "word_count": 41}, {"text": "in working to address the issues raised by stakeholders and maintain public health protections , policymakers may consider issues such as patient access to compounded drugs , drug quality , and necessity of compounding .", "tokens": ["in", "working", "to", "address", "the", "issues", "raised", "by", "stakeholders", "and", "maintain", "public", "health", "protections", ",", "policymakers", "may", "consider", "issues", "such", "as", "patient", "access", "to", "compounded", "drugs", ",", "drug", "quality", ",", "and", "necessity", "of", "compounding", "."], "sentence_id": 33, "word_count": 35}, {"text": "with respect to patient access , some patients have a legitimate medical need for compounded drugs , whereby an fda - approved product would not be medically appropriate treatment .", "tokens": ["with", "respect", "to", "patient", "access", ",", "some", "patients", "have", "a", "legitimate", "medical", "need", "for", "compounded", "drugs", ",", "whereby", "an", "fda", "-", "approved", "product", "would", "not", "be", "medically", "appropriate", "treatment", "."], "sentence_id": 34, "word_count": 30}, {"text": "for these patients , preserving timely access to compounded medications is important , a concern raised by those who support compounding for office - use .", "tokens": ["for", "these", "patients", ",", "preserving", "timely", "access", "to", "compounded", "medications", "is", "important", ",", "a", "concern", "raised", "by", "those", "who", "support", "compounding", "for", "office", "-", "use", "."], "sentence_id": 35, "word_count": 26}, {"text": "drug quality is also a consideration , particularly in the context of patient safety .", "tokens": ["drug", "quality", "is", "also", "a", "consideration", ",", "particularly", "in", "the", "context", "of", "patient", "safety", "."], "sentence_id": 36, "word_count": 15}, {"text": "pharmacies that compound pursuant to section 503a are exempt from cgmp requirements , are not subject to fda registration , and are generally not inspected by the agency unless it is for cause .", "tokens": ["pharmacies", "that", "compound", "pursuant", "to", "section", "503a", "are", "exempt", "from", "cgmp", "requirements", ",", "are", "not", "subject", "to", "fda", "registration", ",", "and", "are", "generally", "not", "inspected", "by", "the", "agency", "unless", "it", "is", "for", "cause", "."], "sentence_id": 37, "word_count": 34}, {"text": "because these pharmacies are not required to register with fda , the agency is often unaware of potential issues with the compounded products or compounding practices until it receives a complaint or adverse event report , which pharmacies are not required to submit .", "tokens": ["because", "these", "pharmacies", "are", "not", "required", "to", "register", "with", "fda", ",", "the", "agency", "is", "often", "unaware", "of", "potential", "issues", "with", "the", "compounded", "products", "or", "compounding", "practices", "until", "it", "receives", "a", "complaint", "or", "adverse", "event", "report", ",", "which", "pharmacies", "are", "not", "required", "to", "submit", "."], "sentence_id": 38, "word_count": 44}, {"text": "for these reasons , among others , fda maintains that compounded drugs pose a higher risk than fda - approved drugs .", "tokens": ["for", "these", "reasons", ",", "among", "others", ",", "fda", "maintains", "that", "compounded", "drugs", "pose", "a", "higher", "risk", "than", "fda", "-", "approved", "drugs", "."], "sentence_id": 39, "word_count": 22}, {"text": "a related policy consideration is necessity .", "tokens": ["a", "related", "policy", "consideration", "is", "necessity", "."], "sentence_id": 40, "word_count": 7}, {"text": "as discussed , fda's interpretation of the prescription requirement has been met with some opposition , and certain stakeholders have argued that compounding for office - use by 503a pharmacies should be allowed because health care providers need to keep certain compounded drugs in stock for immediate administration .", "tokens": ["as", "discussed", ",", "fda", "'s", "interpretation", "of", "the", "prescription", "requirement", "has", "been", "met", "with", "some", "opposition", ",", "and", "certain", "stakeholders", "have", "argued", "that", "compounding", "for", "office", "-", "use", "by", "503a", "pharmacies", "should", "be", "allowed", "because", "health", "care", "providers", "need", "to", "keep", "certain", "compounded", "drugs", "in", "stock", "for", "immediate", "administration", "."], "sentence_id": 41, "word_count": 50}, {"text": "however , fda and outsourcing facility groups have generally disagreed that 503a pharmacies need to compound for office - use .", "tokens": ["however", ",", "fda", "and", "outsourcing", "facility", "groups", "have", "generally", "disagreed", "that", "503a", "pharmacies", "need", "to", "compound", "for", "office", "-", "use", "."], "sentence_id": 42, "word_count": 21}, {"text": "outsourcing facilities created by the cqa are able to produce in bulk while also providing additional patient protections since they are subject to more stringent regulatory requirements ; as such , allowing 503a compounding pharmacies to produce for office - use may not be necessary .", "tokens": ["outsourcing", "facilities", "created", "by", "the", "cqa", "are", "able", "to", "produce", "in", "bulk", "while", "also", "providing", "additional", "patient", "protections", "since", "they", "are", "subject", "to", "more", "stringent", "regulatory", "requirements", ";", "as", "such", ",", "allowing", "503a", "compounding", "pharmacies", "to", "produce", "for", "office", "-", "use", "may", "not", "be", "necessary", "."], "sentence_id": 43, "word_count": 46}, {"text": "if a hospital , clinic , or health care practitioner wants to keep compounded drugs in stock for office - use , they can generally obtain non - patient - specific compounded drugs from outsourcing facilities that are registered under section 503b .", "tokens": ["if", "a", "hospital", ",", "clinic", ",", "or", "health", "care", "practitioner", "wants", "to", "keep", "compounded", "drugs", "in", "stock", "for", "office", "-", "use", ",", "they", "can", "generally", "obtain", "non", "-", "patient", "-", "specific", "compounded", "drugs", "from", "outsourcing", "facilities", "that", "are", "registered", "under", "section", "503b", "."], "sentence_id": 44, "word_count": 43}, {"text": "fda also has stated that allowing pharmacies to compound without a patient - specific prescription may provide less incentive for such entities to register as outsourcing facilities .", "tokens": ["fda", "also", "has", "stated", "that", "allowing", "pharmacies", "to", "compound", "without", "a", "patient", "-", "specific", "prescription", "may", "provide", "less", "incentive", "for", "such", "entities", "to", "register", "as", "outsourcing", "facilities", "."], "sentence_id": 45, "word_count": 28}, {"text": "to help health care providers determine which outsourcing facilities compound the drugs they need for purposes of office - use , fda has issued a list of the drugs that registered outsourcing facilities have produced .", "tokens": ["to", "help", "health", "care", "providers", "determine", "which", "outsourcing", "facilities", "compound", "the", "drugs", "they", "need", "for", "purposes", "of", "office", "-", "use", ",", "fda", "has", "issued", "a", "list", "of", "the", "drugs", "that", "registered", "outsourcing", "facilities", "have", "produced", "."], "sentence_id": 46, "word_count": 36}, {"text": "several other stakeholders , including the pharmaceutical industry , have generally supported fda's prescription requirement guidance .", "tokens": ["several", "other", "stakeholders", ",", "including", "the", "pharmaceutical", "industry", ",", "have", "generally", "supported", "fda", "'s", "prescription", "requirement", "guidance", "."], "sentence_id": 47, "word_count": 18}], "section_names": ["", "background", "pharmacy compounding", "outsourcing facility compounding", "cqa implementation and possible issues for congress", "policy considerations", "appendix. comparison of 503a compounding pharmacies and 503b outsourcing facilities"], "section_lengths": [0, 9, 3, 4, 16, 15, 0]}